Luteolin is a potential inhibitor of COVID-19: An in silico analysis

The severe respiratory syndrome 2019 novel coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread explosively, raising global health concerns. Luteolin shows antiviral properties, but its effect on SARS-CoV-2 and the associated mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenxiang, Yang, Ce, Xia, Jing, Li, Ning, Xiong, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519465/
https://www.ncbi.nlm.nih.gov/pubmed/37746970
http://dx.doi.org/10.1097/MD.0000000000035029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519465/
https://www.ncbi.nlm.nih.gov/pubmed/37746970
http://dx.doi.org/10.1097/MD.0000000000035029

Ejemplares similares